EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis

Fanming Kong, Xinyu Yang, Zhichao Lu, Zongheng Liu, Yang Yang, Ziheng Wang

PeerJ · 2023

DOI: 10.7717/peerj.16167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Fanming Kong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) has long been the deadliest malignancy worldwide, with adenocarcinoma (AD) being the most common pathological subtype. Here we focused on the value of LASTR in LUAD. Using expression analysis, enrichment analysis, immune cell infraction analysis, we found that the expression level of LASTR was significantly increased in LUAD tissue. Meanwhile, LASTR was significantly associated with differential infiltration of various immune cells. Kaplan-Meier survival analysis showed that LUAD related with a poor prognosis in terms of OS, PFI, and DSS compared with high-expression LASTR. The enrichment analysis showed that LASTR is related to the pathays like PI3K-AKT signaling pathway. Thus, the present findings could be helpful in a better understand of LASTR in LUAD. RT-PCR was used to verify the high expression of LASTR in LUAD tissues, and the apoptosis of LUAD cell lines was promoted by CCK8 and Transwell experiments to verify the ability of LASTR to promote the migration and invasion of lung cancer cells in vitro .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCarcinoma, Non-Small-Cell LungLung NeoplasmsAdenocarcinomaHumansPhosphatidylinositol 3-KinasesPrognosisCluster AnalysisBiomarkers

Stichwörter der Autor:innen

BioinformaticsLASTRLUADOnclogy

Substanzen

RNA, Long NoncodingPhosphatidylinositol 3-KinasesBiomarkers

Autor:innen und Institutionen

  • Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
  • Department of Trauma Center, Affiliated Hospital of Nantong University, Jiangsu, China.
  • Department of Clinical Bio-bank, Affiliated Hospital of Nantong University, Jiangsu, China.
  • Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, China.

Zitieren

APA

Kong, F., Yang, X., Lu, Z., Liu, Z., Yang, Y., & Wang, Z. (2023). A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis. PeerJ. https://doi.org/10.7717/peerj.16167

Vancouver

Kong F, Yang X, Lu Z, Liu Z, Yang Y, Wang Z. A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis. PeerJ. 2023. doi:10.7717/peerj.16167

BibTeX
@article{Kong2023,
  author = {Kong, Fanming and Yang, Xinyu and Lu, Zhichao and Liu, Zongheng and Yang, Yang and Wang, Ziheng},
  title = {A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.16167}
}
Kostenlos starten →